A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1998
11/04/1998	EP0874842A1 Mercaptoalkylpeptidyl compounds having an imidazole substituent and their use as inhibitors of matrix metalloproteinases (mmp) and/or tumour necrosis factor (tnf)
11/04/1998	EP0874841A1 1-benzenesulfonyl pyrrolidine derivatives as bradykinin receptor b2 antagonists
11/04/1998	EP0874839A1 Furan- and thiophenecarbothioamide derivatives, their preparation and their use as inhibitors of the replication of hiv-1 and hiv-1 mutants
11/04/1998	EP0874833A1 4,5-dihydronaphth 1,2-c]isoxazoles and derivatives thereof having cns activity
11/04/1998	EP0874830A1 Metalloproteinase inhibitors, pharmaceutical compositions containing them and their pharmaceutical uses, and methods and intermediates useful for their preparation
11/04/1998	EP0874824A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
11/04/1998	EP0874823A1 Tri-substituted phenyl derivatives useful as pde iv inhibitors
11/04/1998	EP0874819A1 Imides as pde iii, pde iv and tnf inhibitors
11/04/1998	EP0874818A1 Novel substituted aryl compounds useful as modulators of acetylcholine receptors
11/04/1998	EP0874808A1 Biphenyl hydroxamate inhibitors of matrix metalloproteinases
11/04/1998	EP0874645A2 Perfluoroalkyl-containing metal complexes and their use in nmr diagnostics
11/04/1998	EP0874639A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein
11/04/1998	EP0874625A1 Indane derivatives for antipsychotic compositions
11/04/1998	EP0874621A1 Pharmaceutical compositions
11/04/1998	EP0714392B1 Heterocycles useful as neurokinin antagonists
11/04/1998	EP0696270B1 4-amino-fluorobenzamides and their use as cytotoxic prodrugs
11/04/1998	EP0656950B1 Tat-derived transport polypeptides
11/04/1998	CN1198158A Bicyclic 4-aralkylaminopyrimidine derivatives as tyrosine kinase inhibitors
11/04/1998	CN1198098A Use of muteins of wild-type cytokines as immunogens
11/04/1998	CN1198096A C-proteinase inhibitor for treatment of disorders related to overproduction of collagen
11/04/1998	CN1197797A New heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
11/04/1998	CN1197664A Use of extract from salvia officinalis for producing medicament for combating dupuytren's contracture
11/03/1998	US5831115 Inhibitors of squalene synthase and protein farnesyltransferase
11/03/1998	US5831094 Difluoro statone antiviral analogs
11/03/1998	US5831072 Inhibitor of deaminase
11/03/1998	US5831056 Secreted proteins and polynucleotides encoding them
11/03/1998	US5830995 Fanphiregulins: a family of heparin-binding epithelial cell growth factors
11/03/1998	US5830920 Prevention growth of smooth muscle cells
11/03/1998	US5830917 L-N6 -(1-iminoethyl) lysine derivatives useful as nitric oxide synthase inhibitors
11/03/1998	US5830915 Oral diseases; skin disorders; antiinflammatory agents
11/03/1998	US5830914 Apoptosis-controlling agent
11/03/1998	US5830906 Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them
11/03/1998	US5830901 Tetrahydropyridinylmethyl derivatives of pyrrolo 2,3-B!pyridine
11/03/1998	US5830892 Piperidine and morphonline derivatives and their use as therapeutic agents
11/03/1998	US5830886 Steroid sulphatase inhibitors
11/03/1998	US5830880 Gene therapy of tumors with an endothelial cell-specific, cell cycle-dependent active compound
11/03/1998	US5830877 Method, compositions and devices for administration of naked polynucleotides which encode antigens and immunostimulatory
11/03/1998	US5830870 Prevent loss of muscle mass
11/03/1998	US5830850 Methods for the treatment of bone resorption disorders, including osteoporosis
11/03/1998	US5830756 DNA and expression vector encoding IκB Protein
11/03/1998	US5830705 Procaryotic or eukaryotic exoression of an exogenous dna sequence
11/03/1998	US5830671 Method for assaying for modulators of cytokines of the TFG β superfamily
11/03/1998	US5830472 Purified sperm surface antigen, monoclonal antibody therefor and applications therefor
11/03/1998	US5830464 Compositions and methods for the treatment and growth inhibition of cancer using heat shock/stress protein-peptide complexes in combination with adoptive immunotherapy
11/03/1998	US5830455 Method of treatment using a therapeutic combination of α interferon and free radical scavengers
11/03/1998	US5830453 Use of IL-13 to induce 15-lipoxygenase
11/03/1998	US5830436 Method of mucociliary clearance in cystic fibrosis patients using alkylaryl polyether alcohol polymers
11/03/1998	CA1340112C Supression of cell proliferation by decorin
10/1998
10/30/1998	CA2231741A1 Novel g-protein coupled receptor (hfgan72y)
10/30/1998	CA2228742A1 Crfg-1, a target and marker for chronic renal failure
10/30/1998	CA2228736A1 Crfg-1b, a target and marker for chronic renal failure
10/29/1998	WO1998048025A2 Regulatory system for inducible expression of genes with lambdoid promoters
10/29/1998	WO1998048024A1 Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins
10/29/1998	WO1998048017A1 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir)
10/29/1998	WO1998047911A1 Rnase l activators and antisense oligonucleotides effective to treat telomerase-expressing malignancies
10/29/1998	WO1998047903A1 Crf antagonistic thiophenopyridines
10/29/1998	WO1998047900A1 Heterocyclic compounds and their preparation and use
10/29/1998	WO1998047898A1 5-aryl-3-(8-azabicyclo(3.2.2)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands
10/29/1998	WO1998047892A1 Substituted imidazoles useful in the treatment of inflammatory diseases
10/29/1998	WO1998047890A1 Substituted benzopyran derivatives for the treatment of inflammation
10/29/1998	WO1998047885A1 A bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5ht1a, 5ht1b and 5ht1d receptor antagonistic activity
10/29/1998	WO1998047874A1 Crf antagonistic quino- and quinazolines
10/29/1998	WO1998047871A1 Process for making 2-aryl-3-aryl-5-halo pyridines useful as cox-2 inhibitors
10/29/1998	WO1998047869A1 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
10/29/1998	WO1998047534A1 Stabilized medicaments containing cysteinyl derivatives
10/29/1998	WO1998047523A1 Peptidyl-2-amino-1-hydroxyalkanesulfonic acid cysteine protease inhibitors
10/29/1998	WO1998047522A1 Bradykinin analogs as selective inhibitors of cell activation
10/29/1998	WO1998047515A1 THE USE OF α-METHYL-P-TYROSINE TO INHIBIT MELANIN PRODUCTION IN IRIS MELANOCYTES
10/29/1998	WO1998047514A1 Use of an nk-1 receptor antagonist and an ssri for treating obesity
10/29/1998	WO1998047513A1 Use of nk-1 receptor antagonists for treating eating disorders
10/29/1998	WO1998047511A1 Use of mizolastine for preparing a medicine for treating inflammation
10/29/1998	WO1998047509A1 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
10/29/1998	WO1998047502A1 IBUPROFEN THIOESTERS AS INHIBITORS OF Nf-λB-DEPENDENT PAIN AND INFLAMMATION MEDIATOR FORMATION
10/29/1998	WO1998047498A1 Neuroprotective compounds and uses thereof
10/29/1998	WO1998047481A1 Use of 5ht3 antagonists for promoting intestinal lavage
10/29/1998	WO1998041538A3 Novel human cytokine/steroid receptor protein
10/29/1998	WO1998034121A3 Isolated p27 protein and methods for its production and use
10/29/1998	WO1998030696A3 Secreted proteins and polynucleotides encoding them
10/29/1998	WO1998022589A3 Survivin, a protein that inhibits cellular apoptosis, and its modulation
10/29/1998	WO1998009953A3 Azinyloxy-and phenoxy-diaryl-carboxylic acid derivatives, their preparation and use as mixed eta/etb endothelin receptor antagonists
10/29/1998	CA2297176A1 Substituted imidazoles useful in the treatment of inflammatory diseases
10/29/1998	CA2288172A1 A bicyclic aryl or a bicyclic heterocyclic ring containing compounds having a combined 5ht1a, 5ht1b and 5ht1d receptor antagonistic activity
10/29/1998	CA2288027A1 Bradykinin analogs as selective inhibitors of cell activation
10/29/1998	CA2287887A1 The use of .alpha.-methyl-p-tyrosine to inhibit melanin production in iris melanocytes
10/29/1998	CA2287501A1 Ibuprofen thioesters as inhibitors of nf-kb-dependent pain and inflammation mediator formation
10/29/1998	CA2287487A1 Use of nk-1 receptor antagonists for treating eating disorders
10/29/1998	CA2287397A1 Use of an nk-1 receptor antagonist and an ssri for treating obesity
10/29/1998	CA2287314A1 Rnase l activators and antisense oligonucleotides effective to treat telomerase-expressing malignancies
10/29/1998	CA2287255A1 Carbocyclic and heterocyclic substituted semicarbazones and thiosemicarbazones and the use thereof
10/29/1998	CA2287162A1 Neuroprotective compounds and uses thereof
10/29/1998	CA2286933A1 Type ii tgf-beta receptor/immunoglobulin constant region fusion proteins
10/29/1998	CA2286673A1 Method of using cyclooxygenase-2 inhibitors in the prevention of cardiovascular disorders
10/29/1998	CA2286106A1 5-aryl-3-(8-azabicyclo(3.2.1)oct-3-yl)-1,3,4-oxadiazol-2(3h)-one derivatives as 5-ht4 receptor ligands
10/29/1998	CA2272292A1 Crf antagonistic thiophenopyridines
10/28/1998	EP0874045A1 Novel dnas and process for producing proteins by using the same
10/28/1998	EP0873993A1 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
10/28/1998	EP0873414A1 Galactopyranosides and their use
10/28/1998	EP0873407A1 Apo-2 ligand
10/28/1998	EP0873406A2 Protein induced by deprenyl
10/28/1998	EP0873404A1 Angiotensin converting enzyme inhibitors

1 ... 1266 1267 1268 1269 1270 1271 1272 1273 1274 1275 1276 1277 1278 1279 1280 1281 1282 1283 1284 1285 1286 ... 1564